HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Artelo Biosciences (NASDAQ:ARTL) and maintained a price target of $5.
June 05, 2024 | 10:47 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Artelo Biosciences and maintained a price target of $5.
The reiteration of a Buy rating and maintenance of a $5 price target by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100